Exchange Traded Concepts’s 2seventy bio TSVT Stock Holding History

Exchange Traded Concepts’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25,735	Closed	-$127K	–	1506
2025 Q1	$127K	Sell	25,735 -9,081	-26%	-$28.9K	﹤0.01%	1074
2024 Q4	$102K	Hold	34,816	–	–	﹤0.01%	1138
2024 Q3	$164K	Sell	34,816 -20,064	-37%	-$90.5K	﹤0.01%	1023
2024 Q2	$211K	Sell	54,880 -17,073	-24%	-$77K	0.01%	869
2024 Q1	$385K	Buy	71,953 +37,337	+108%	+$176K	0.01%	692
2023 Q4	$148K	Buy	34,616 +8,778	+34%	+$27K	﹤0.01%	834
2023 Q3	$101K	Buy	25,838 +13,802	+115%	+$90.5K	﹤0.01%	888
2023 Q2	$122K	Buy	+12,036	New	+$127K	﹤0.01%	906

Other funds holding TSVT

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Exchange Traded Concepts's TSVT Position: Q2 2025 in Review

Exchange Traded Concepts sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 25,735 shares — an estimated $127K sold.

Exchange Traded Concepts first reported a position in TSVT in Q2 2023 and held it in 8 quarters. The position peaked at $385K in Q1 2024. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

Exchange Traded Concepts reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
Exchange Traded Concepts sold 25,735 2seventy bio shares in Q2 2025, an estimated $127K.
Exchange Traded Concepts first reported a position in 2seventy bio in Q2 2023 and held it in 8 quarters.
Exchange Traded Concepts's 2seventy bio position peaked at $385K in Q1 2024.
2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.